Aetna Inc. (NYSE:AET) to Post Q4 2017 Earnings of $1.31 Per Share, Oppenheimer Holdings Forecasts
Aetna Inc. (NYSE:AET) – Research analysts at Oppenheimer Holdings dropped their Q4 2017 earnings estimates for Aetna in a research report issued on Thursday. Oppenheimer Holdings analyst M. Wiederhorn now expects that the company will post earnings per share of $1.31 for the quarter, down from their previous estimate of $1.66.
Several other research analysts have also recently commented on AET. UBS AG reiterated a “buy” rating and issued a $160.00 target price (up from $147.00) on shares of Aetna in a report on Wednesday, May 17th. BidaskClub cut shares of Aetna from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Jefferies Group LLC reiterated a “hold” rating and issued a $163.00 target price on shares of Aetna in a report on Friday. Royal Bank Of Canada raised their target price on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a report on Friday. Finally, Deutsche Bank AG raised their target price on shares of Aetna from $144.00 to $157.00 and gave the stock a “hold” rating in a report on Thursday, July 13th. Eight investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $155.46.
TRADEMARK VIOLATION WARNING: “Aetna Inc. (NYSE:AET) to Post Q4 2017 Earnings of $1.31 Per Share, Oppenheimer Holdings Forecasts” was published by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2017/08/07/aetna-inc-nyseaet-to-post-q4-2017-earnings-of-1-31-per-share-oppenheimer-holdings-forecasts.html.
Aetna (NYSE AET) opened at 156.79 on Monday. The firm has a market cap of $52.01 billion, a price-to-earnings ratio of 47.82 and a beta of 0.54. The stock has a 50 day moving average of $153.22 and a 200-day moving average of $137.42. Aetna has a 52-week low of $104.59 and a 52-week high of $161.69.
Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. The business had revenue of $15.52 billion during the quarter, compared to analyst estimates of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company’s revenue was down 2.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.21 earnings per share.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend was Tuesday, July 11th. Aetna’s payout ratio is presently 43.67%.
In related news, EVP Margaret M. Mccarthy sold 27,028 shares of the firm’s stock in a transaction that occurred on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,008,606.49. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Chairman Mark T. Bertolini sold 103,547 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total transaction of $14,578,382.13. Following the transaction, the chairman now directly owns 659,888 shares in the company, valued at approximately $92,905,631.52. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.
A number of institutional investors have recently modified their holdings of the stock. FTB Advisors Inc. increased its position in shares of Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock valued at $125,000 after buying an additional 97 shares during the period. Signature Estate & Investment Advisors LLC bought a new position in shares of Aetna during the first quarter valued at approximately $133,000. Liberty Capital Management Inc. increased its position in shares of Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after buying an additional 629 shares during the period. Horan Capital Management bought a new position in shares of Aetna during the first quarter valued at approximately $157,000. Finally, Guardian Life Insurance Co. of America increased its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares during the period. 91.73% of the stock is currently owned by hedge funds and other institutional investors.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.